<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1392</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2014</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>28</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture</title>
	<subject_fa>Virology </subject_fa>
	<subject>Virology </subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt; Background &lt;/strong&gt;:Wide distribution and low half-life of acyclovir has led to a high dose consumption of the drug. Recent studies have shown that encapsulation of acyclovir in nano-carriers can increase effectiveness and decrease its side effects. We investigated the inhibitory effect of acyclovir loaded nano-niosomes against herpes simplex virus type-1 (HSV-1) in cell culture. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Methods &lt;/strong&gt;: In-vitro cytotoxicity study of empty niosomes (E-N), acyclovir loaded niosomes (ACV-N) and ACV as a free drug against HeLa cell line was performed by MTT assay and the viral titers was tested by TCID50 assay. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Results &lt;/strong&gt;: The results indicated that a significant higher antiviral activity for acyclovir loaded nano-niosomes of about 3 times in comparison with free drug. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Conclusion &lt;/strong&gt;: The results of this study revealed ACV-N have a higher antiviral activity compared with free drug it could be a suitable carrier for delivery of acyclovir in the treatment of HSV-1 infections. &lt;/p&gt;&lt;p&gt;  &lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Nano-niosomes, Herpes simplex virus, Cytotoxicity.</keyword>
	<start_page>641</start_page>
	<end_page>645</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-730&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Seyed Hamidreza </first_name>
	<middle_name></middle_name>
	<last_name>Monavari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hrmonavari@yahoo.com</email>
	<code>200319475328460013296</code>
	<orcid>200319475328460013296</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Virology, School of Medicine, Iran University of Medical Sciences,Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad Javad </first_name>
	<middle_name></middle_name>
	<last_name>Mirzaeiparsa</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mparsa1389@gmail.com</email>
	<code>200319475328460013297</code>
	<orcid>200319475328460013297</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Advanced Medical Technologies, Tehran University of Medical Sciences,Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Bahram </first_name>
	<middle_name></middle_name>
	<last_name>Bolouri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>tankbolouri@yahoo.com</email>
	<code>200319475328460013298</code>
	<orcid>200319475328460013298</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Advanced Medical Technologies, Iran University of Medical Sciences,Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Soltan Ahmed </first_name>
	<middle_name></middle_name>
	<last_name>Ebrahimi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ebrahimi@iums.ac.ir</email>
	<code>200319475328460013299</code>
	<orcid>200319475328460013299</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology, School of Medicine, Iran University of Medical Scinces,Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Angila </first_name>
	<middle_name></middle_name>
	<last_name>Ataei-pirkooh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email> gila@inbox.com</email>
	<code>200319475328460013300</code>
	<orcid>200319475328460013300</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Virology, School of Medicine, Iran University of Medical Sciences,Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
